Stay updated on Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Recruitment status now indicates recruitment is closed, and the page adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a clarified Intervention/Treatment label and a new revision banner (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-12T12:28:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's software or documentation. This change does not alter the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-06-05T08:25:18.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing v3.5.3, indicating a software patch. No study content or data are changed.
    Difference
    0.0%
    Check dated 2026-05-15T04:46:55.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3 instead of v3.5.2, signaling a minor version update to the page metadata. This change does not modify study content, results, or eligibility details.
    Difference
    0.0%
    Check dated 2026-04-30T17:27:09.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.2; no changes to study details, eligibility criteria, or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-16T10:24:32.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Adds a Publications section featuring the J Clin Oncol article 'Induction Nivolumab Before Chemoradiation in High-Risk HPV-Driven Oropharynx Cancers: IMMUNEBOOST-HPV.' Publications are automatically filled from PubMed.
    Difference
    0.2%
    Check dated 2026-03-25T20:27:34.000Z thumbnail image

Stay in the know with updates to Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.